CN102552469A - Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension - Google Patents

Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension Download PDF

Info

Publication number
CN102552469A
CN102552469A CN2011104630035A CN201110463003A CN102552469A CN 102552469 A CN102552469 A CN 102552469A CN 2011104630035 A CN2011104630035 A CN 2011104630035A CN 201110463003 A CN201110463003 A CN 201110463003A CN 102552469 A CN102552469 A CN 102552469A
Authority
CN
China
Prior art keywords
product
hyperlipidemia
hypertension
diabetes
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011104630035A
Other languages
Chinese (zh)
Inventor
林祖宪
林健
扶春福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2011104630035A priority Critical patent/CN102552469A/en
Publication of CN102552469A publication Critical patent/CN102552469A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension as well as a preparation method of the product; specifically the health-care product is prepared by uniformly mixing the medicinal and edible guava young fruit, hawthorn, gynostemma pentaphylla and balsam pear in proportion; after being smashed and sterilized, the guava young fruit, hawthorn, gynostemma pentaphylla and balsam pear are made into tea bags; and the refined and concentrated dry product can be made into health-care Chinese patent drug. Modern pharmacological studies show that the components relating to the invention have no toxic or side effects and combined action in reducing blood sugar, blood fat and blood pressure, so the product can be taken by three high-disease patients for a long term. If the product is taken by the three high-disease patients for a long term at the primary period of the disease, the disease can be effectively controlled by matching diet control and physical exercise, and even can be treated; the toxic or side effects of chemical synthesis medicine can be effectively reduced when the product is taken at the middle and later periods of the three high-disease; after the product is taken for 30-60 days, the indexes, such as visual blood biochemical index and the like, are improved; the chemical synthesis medicine is gradually reduced; and partial patients can stop taking the products.

Description

A kind of to diabetes, hyperlipidemia, the hypertensive health product that the auxiliary treatment effect is arranged
Technical field
The invention belongs to field of health care products, being specifically related to a kind ofly has the health product of auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, and it is that fruit food with integration of edible and medicinal herbs is raw material, can be made into dosage forms such as teabag, tablet, electuary, capsule.
Background technology
Change along with growth in the living standard and rhythm of life; Be called as " affluenza " " three-hypers disease " (be hyperglycemia. hypertension and hyperlipidemia) as " the old times king thanks to a preceding swallow; fly into common people house "; The healthy commonly encountered diseases of middle-aged and elderly people more than 50 years old particularly, every year is died from the number of " three-hypers disease " disease up to 1,500 ten thousand people in the whole world, and it is the first to occupy the various causes of the death." three-hypers disease " disease has become the human dead cause of disease the highest " No.1 killer ", also is " the noiseless demon " of health of people! " three-hypers disease " disease has the characteristics of " sickness rate is high, disability rate is high, mortality rate is high, relapse rate is high, and complication is many " formation " four is high by more than one ", and at present, China's " three-hypers disease " disease patient has surpassed 2.7 hundred million people
Divide secret and cardiovascular and cerebrovascular disease category in " three-hypers disease " is under the jurisdiction of. often suffer from send out multifactor in heredity and overnutrition etc. at least in medical science level " three-hypers disease " at present in case still there is not the radical cure method. that is to say that suffering from this disease needs lifelong medication.
Modern medicine study: diabetes; High fat of blood is even hypertension. and the description of obesity is four balsam pears on Teng. seldom exists with independent sick the kind. early detection. timely drug intervention. but along with transfer age time increases. normal three sick connection appearance. finish all the life with complication at last.
Modern medicine treatment at present " three-hypers disease: antidiabetic drug such as peroral dosage form sulphanylureas. biguanides. benzoic acid derivative and injection insulin etc.; Antilipemic such as Statins, the special class of shellfish etc.; The inhibition of conversion such as antihypertensive such as calcium channel blocker, angiotensin enzyme, beta-blocker etc.
Clinical data demonstrate: The above synthetic drugs Although effective and reliable, but long-term use of liver and kidney side effects are likely to occur, such as liver transaminase increased, removal rate decreased renal creatinine Cheongju, will addiction, drug resistance; the gastrointestinal, liver and kidney cause varying degrees of damage.Also has above-mentioned chemical synthetic drug good effect often in several weeks in the early stage in addition; Using has 10 to 15% patients to lose curative effect suddenly after 6 to 12 months; Agnogenio, old person more be prone to be taken place, and is often looked by Hu and causes the state of an illness to increase the weight of even cause complication to take place and dead.
Motherland's medical science is that so many as to make the ox carrying them perspire and to fill a house to the rafters to " three-hypers disease " research with the treatment theory, often is unable to undergo repetition because of curative effect and does not possess promotional value widely.And be regarded as healthy strong helper; Again by the sure occurring in nature of people; The gratifying achievement of especially the single research of some fruit or vegetable Chinese herbal medicine having been got by modern medicine; Like clinical practice of arteannuin, berberine etc., marvellous strength has been brought into play in active ingredient contained in the plant.
Summary of the invention
The realization of the object of the invention also is according to coming from the sick effective single proved recipe of modern treatment among the people " three-hypers disease " basis; From modern medicine pharmacological research achievement; Preferred have have three to fall effect certainly; Consider that simultaneously " three-hypers disease " needs the characteristic of long-term prescription, optimize with edible fruit of integration of edible and medicinal herbs and vegetable Chinese herbal medicine; Fructus psidii guajavae immaturus, Fructus Crataegi, Herb Gynostemmae Pentaphylli, Fructus Momordicae charantiae.Become a kind of good to eat health tea or " the strong font size of state's food " Chinese patent medicine medicine that has no side effect, can supply this type of patient to take for a long time through reasonable component.
1, for solving above-mentioned technical barrier, the present invention has the auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, it is characterized in that it is to be processed by the dry product raw material of following weight proportioning.
Fructus psidii guajavae immaturus young fruit 40~80 Fructus Crataegis 20~40 Herb Gynostemmae Pentaphylli 10~30 Fructus Momordicae charantiaes 10~30
2, the preferred weight proportion of above-mentioned each raw material is;
Fructus psidii guajavae immaturus young fruit 60~80 Fructus Crataegis 15~40 Herb Gynostemmae Pentaphylli 10~20 Fructus Momordicae charantiaes 10~20
3, the best weight proportion of above-mentioned each raw material is;
Fructus psidii guajavae immaturus young fruit 65 Fructus Crataegis 15 Herb Gynostemmae Pentaphylli 10 Fructus Momordicae charantiaes 10
4, described diabetes, hyperlipidemia, hypertension there are the preparation method of teabag of auxiliary treatment effect according to 1,2 or 3 of above-mentioned weight proportion, it is characterized in that; Taking by weighing each raw material by prescription through mix homogeneously, pulverizing, sterilization is.
5, according to 1,2 or 3 described Chinese patent medicine method for preparinies that diabetes, hyperlipidemia, hypertension had the auxiliary treatment effect of above-mentioned weight proportion; It is characterized in that: by prescription take by weighing each raw material through mix homogeneously, pulverize after the dry thing through concentrating, refining again, can be made into tablet, electuary or capsule etc. " the strong font size of state's food " Chinese patent medicine.
Distinguishing feature of the present invention also has: the single in the prescription of the present invention, " three-hypers disease " among the people patient often selects at random and makes tea and take, often because of taste is puckery partially, meta-acid, sweet partially, inclined to one side hardship can't be taken for a long time.Each composition of prescription among the present invention or the domestic finished product of compound recipe composition are like Fructus psidii guajavae immaturus teabag or electuary, Fructus Crataegi teabag or electuary, Herb Gynostemmae Pentaphylli teabag or electuary, balsom pear tea bag or electuary etc.Because composite factors such as compatibility is unreasonable often cause gastrointestinal upset such as taking back mouthfeel discomfort, pantothenic acid, constipation or rare pool, and limited the optimum efficiency that can take for a long time, through reasonable compatibility, all dosage forms of the present invention can effectively overcome above weakness.
The specific embodiment
Embodiment 1; Mainly be to provide clinical with the teabag dosage form, it is following specifically to take description:
[main component]: Fructus psidii guajavae immaturus young fruit Fructus Crataegi Herb Gynostemmae Pentaphylli Fructus Momordicae charantiae etc.
[scope of application]: to diabetes. hyperlipidemia. hypertension etc. " three-hypers disease " have the auxiliary treatment effect.
[usage and dosage]: but 1 to 3 bag of every day. after brewing, drinks by 200 to 500 milliliters in hot boiled water. and the repeated multiple times bubble is used. and obeyed the same day.
[packing specification]: 6 gram/bag x30 sachets/pouches
[quality guarantee period]: 12 months
[storage practice]: put shady and cool dry place.
[points for attention]:
1, this teabag can not replace the medicine taken originally. but can effectively improve the Liver and kidney toxic and side effects of chemosynthesis medicine.
2, take 20 days continuously after. inspection situations such as visual blood biochemistry are by the former drug dosage of using of ashamed minimizing.Part patient combines can pursue ashamed inactive Western medicine after diet control and the exercise.
3, clinically do not see taking the clinical report that the play of this prescription composition poison is used. can take for a long time.
4, should as taking conscious self the doing not feel like oneself in these article back. stop can disappear automatically after the drink.
5, these article character changes as caking. ban use of when mouldy.
Embodiment 2; Be to be basic Chu with the teabag dosage form, use these article according to differential diagnosis in tcm opinion vermachen, the specific embodiment is;
1, " three-hypers disease " is partial to type of deficiency of both QI and YIN; The companion sees the few tongue of xerostomia polydipsia, fatigue and weak, dysphoria with feverish sensation in the chest palms and soles, red tongue, the unable person of weak pulse, can drink to add Chinese medicine Radix Panacis Quinquefolii gram every days 3~9 and be taken after being infused in hot water or decoction simultaneously.
2, " three-hypers disease " is partial to dryness heat exuberance type; The companion sees build obesity, polyphagia polyphagia, skin itching or gives birth to furuncle and phyma, constipation. yellow fur or greasy, rolling pulse or stringy and rapid pulse person, can drink to add to restrain Chinese medicine embryo nelumbinis every days 3~9 and be taken after being infused in hot water or decoction simultaneously.
3 " three-hypers diseases " are qi stagnation and blood stasis type relatively; Companion meeting color is dark and gloomy, soreness of the waist and knees, Hiccough and deaf, binocular are dim-sighted, purplish tongue or ecchymosis, the unable person of hesitant pulse are arranged, and can drink to add Chinese medicine Fructus Lycii gram every days 3~9 and be taken after being infused in hot water or decoction simultaneously.

Claims (5)

1. one kind has the health product of auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, it is characterized in that it is to be processed by the dry product raw material of following weight proportioning:
Fructus psidii guajavae immaturus young fruit 40~80 Fructus Crataegis 20~40 Herb Gynostemmae Pentaphylli 10~30 Fructus Momordicae charantiaes 10~30.
2. according to claim 1 have the health product of auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, it is characterized in that the weight proportion of each raw material is:
Fructus psidii guajavae immaturus young fruit 60~80 Fructus Crataegis 15~40 Herb Gynostemmae Pentaphylli 10~20 Fructus Momordicae charantiaes 10~20.
3. according to claim 2 have the health product of auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, it is characterized in that the weight proportion of each raw material is:
Fructus psidii guajavae immaturus young fruit 65 Fructus Crataegis 15 Herb Gynostemmae Pentaphylli 10 Fructus Momordicae charantiaes 10.
4. claim 1,2 or 3 describedly has the method for preparing of the health product of auxiliary treatment effect to diabetes, hyperlipidemia, hypertension, it is characterized in that: take by weighing each raw material through mix homogeneously, pulverizing, sterilization by prescription, be distributed into the teabag of every parcel 3~9 grams.
5. claim 1, the 2 or 3 described preparation components that diabetes, hyperlipidemia, hypertension had the health product of auxiliary treatment effect; By prescription take by weighing each raw material through mix homogeneously, pulverize after the dry thing through concentrating, refining again, can be made into tablet, electuary or capsule etc. " the strong font size of state's food " Chinese patent medicine.
CN2011104630035A 2011-12-28 2011-12-28 Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension Pending CN102552469A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011104630035A CN102552469A (en) 2011-12-28 2011-12-28 Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011104630035A CN102552469A (en) 2011-12-28 2011-12-28 Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension

Publications (1)

Publication Number Publication Date
CN102552469A true CN102552469A (en) 2012-07-11

Family

ID=46399924

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011104630035A Pending CN102552469A (en) 2011-12-28 2011-12-28 Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension

Country Status (1)

Country Link
CN (1) CN102552469A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102763884A (en) * 2012-07-23 2012-11-07 广西金赛保健品有限责任公司 Health-care beverage of guava and making method of health-care beverage
CN103169793A (en) * 2013-02-27 2013-06-26 李清元 Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus
CN103504077A (en) * 2013-09-10 2014-01-15 安徽省天旭茶业有限公司 Preparation method of dried lactuca green tea beverage
CN105533687A (en) * 2015-12-10 2016-05-04 张友兰 Guava buccal tablets

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1180545A (en) * 1996-10-24 1998-05-06 谢春生 Compound bitter gourd preparation
WO2001051088A1 (en) * 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
CN1647675A (en) * 2005-03-11 2005-08-03 郭道勇 Natural liver protection and fat clearing product
CN1686242A (en) * 2005-04-11 2005-10-26 四川科伦药业股份有限公司 Composition possessing therapeutic effect for high blood fat and heart brain blood vessel diseases
JP2009242250A (en) * 2008-03-28 2009-10-22 Nippon Kanpo Kenkyusho:Kk Hypoglycemic agent
CN101837052A (en) * 2010-06-21 2010-09-22 戴俊腾 Herba saussureae involucratae medicinal granules and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1180545A (en) * 1996-10-24 1998-05-06 谢春生 Compound bitter gourd preparation
WO2001051088A1 (en) * 2000-01-07 2001-07-19 Anthony Cincotta Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
CN1647675A (en) * 2005-03-11 2005-08-03 郭道勇 Natural liver protection and fat clearing product
CN1686242A (en) * 2005-04-11 2005-10-26 四川科伦药业股份有限公司 Composition possessing therapeutic effect for high blood fat and heart brain blood vessel diseases
JP2009242250A (en) * 2008-03-28 2009-10-22 Nippon Kanpo Kenkyusho:Kk Hypoglycemic agent
CN101837052A (en) * 2010-06-21 2010-09-22 戴俊腾 Herba saussureae involucratae medicinal granules and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102763884A (en) * 2012-07-23 2012-11-07 广西金赛保健品有限责任公司 Health-care beverage of guava and making method of health-care beverage
CN103169793A (en) * 2013-02-27 2013-06-26 李清元 Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus
CN103169793B (en) * 2013-02-27 2014-07-30 李清元 Medicine for treating hypertension, hyperlipoidemia and diabetes mellitus
CN103504077A (en) * 2013-09-10 2014-01-15 安徽省天旭茶业有限公司 Preparation method of dried lactuca green tea beverage
CN103504077B (en) * 2013-09-10 2015-09-23 安徽省天旭茶业有限公司 The preparation method of the dry green tea beverage of a kind of tongue
CN105533687A (en) * 2015-12-10 2016-05-04 张友兰 Guava buccal tablets

Similar Documents

Publication Publication Date Title
Sweeney et al. Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration
CN101972462B (en) Alcohol-relieving healthcare product
CN101695328B (en) Dendrobium tea
CN102669667A (en) Health food with dual functions of protecting liver and adjusting blood fat and preparation method thereof
CN105532998A (en) Health-care tea containing cordyceps militaris and preparation method thereof
CN105998762A (en) Fiveleaf gynostemma herb containing healthcare pharmaceutical composition for preventing hyperlipidemia, hypertension and hyperglycemia and gout
CN101990975B (en) Chinese pagodatree tea and preparation method
CN103735943B (en) Pharmaceutical composition that a kind for the treatment of is had loose bowels and its production and use
CN102552469A (en) Health-care product with assistant treatment effect on diabetes, hyperlipidemia and hypertension
CN103479691B (en) Fat-reducing liver-protecting Chinese medicine composition
CN102727787B (en) Drug with characteristics of rapid transaminase lowering and live protection
CN103719672A (en) Medical rice gruel capable of nourishing Qi and blood
CN103920140B (en) A kind of people is with blood sugar lowering Weight-reducing and lipid-lowering compound preparation
CN102698100A (en) Oral solution for treating diabetes mellitus
CN102552692A (en) Anoectochilus formosanus compound alcohol-relieving and liver-protecting capsule and preparation method thereof
CN102000250B (en) Black-bone chicken health-care medicament as well as preparation method and applications thereof
CN103933453A (en) Medicine composition for treating dyspepsia-induced damp stagnation
CN103977390A (en) Method for preparing ginger-onion medicinal liquor composition and application thereof
CN103783119A (en) Chinese yam and buckwheat biscuit having healthcare effect on diabetes
CN105998196A (en) Blood sugar decreasing healthcare pharmaceutical composition prepared from fiveleaf gynostemma herb
CN105853505A (en) Qi-and-lung-tonifying healthcare medicine composition containing five-leaf gynostemma herb
CN101612254A (en) A kind of pharmaceutical composition and preparation method thereof with resisting fatigue, immunoregulation effect
CN104886252A (en) Compound traditional Chinese medicine antialcoholic yogurt and preparation technology thereof
CN104474337A (en) Preparation method of Chinese patent health granule containing green tea extract
CN103877554A (en) Pharmaceutical composition for treating heart disease and preparation method and use thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120711